FXI
Showing 1 - 25 of 41
Healthy Participants Trial in Toronto (IONIS FXI-LRx, Placebo)
Completed
- Healthy Participants
- IONIS FXI-LRx
- Placebo
-
Toronto, Ontario, CanadaBioPharma Services Inc.
Jan 13, 2022
Lymphoma, Malignant Solid Tumor, Plasma Cell Myeloma Trial in Portland (Xisomab 3G3)
Recruiting
- Lymphoma
- +2 more
- Xisomab 3G3
-
Portland, OregonOHSU Knight Cancer Institute
Feb 28, 2022
End-stage Renal Disease (ESRD) Trial in Santiago De Compostela, Alcalá De Henares (ISIS 416858, Placebo)
Completed
- End-stage Renal Disease (ESRD)
- ISIS 416858
- Placebo
-
Santiago De Compostela, A Coruna, Spain
- +1 more
Dec 22, 2022
Thrombosis Trial in Perth (SRSD107, Placebo)
Not yet recruiting
- Thrombosis
- SRSD107
- Placebo
-
Perth, Other (Non U.s.), AustraliaLinear Clinical Research
Nov 2, 2023
Healthy Volunteer Trial in Leeds (REGN7508 (IV), REGN7508 (SC), Matching Placebo (IV))
Recruiting
- Healthy Volunteer
- REGN7508 (IV)
- +3 more
-
Leeds, United KingdomLabcorp Clinical Research Unit
Jan 30, 2023
Healthy Volunteers Trial in Edegem (REGN9933, Placebo)
Recruiting
- Healthy Volunteers
- REGN9933
- Placebo
-
Edegem, Antwerp, BelgiumRegeneron Study Site
Jul 1, 2022
Healthy Volunteers Trial in Perth (SHR2285)
Completed
- Healthy Volunteers
-
Perth, Western Australia, AustraliaLinear Clinical research
Feb 21, 2022
Thrombosis Trial in Nanjing (Aspirin?clopidogrel? or SHR2285, Aspirin?ticagrelor? or SHR2285)
Completed
- Thrombosis
- Aspirin、clopidogrel、placebo or SHR2285
- Aspirin、ticagrelor、placebo or SHR2285
-
Nanjing, Jiangsu, ChinaNanjing Drum Tower Hospital
Jun 30, 2022
Menstrual Bleeding, Heavy Trial in Portland (Sample Collection and Endometrial Biopsy)
Not yet recruiting
- Menstrual Bleeding, Heavy
- Sample Collection and Endometrial Biopsy
-
Portland, OregonOHSU
May 8, 2023
Healthy Adult Subjects Trial in Beijing (CRB4101, Placebo)
Recruiting
- Healthy Adult Subjects
- CRB4101
- Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Nov 29, 2022
End Stage Renal Disease Requiring Hemodialysis Trial in Worldwide (BAY2976217, Placebo)
Completed
- End Stage Renal Disease Requiring Hemodialysis
- BAY2976217
- Placebo
-
Clovis, California
- +68 more
Jan 20, 2023
Renal Dialysis Trial in Worldwide (BAY1213790, 0.9% sodium chloride solution)
Completed
- Renal Dialysis
- BAY1213790
- 0.9% sodium chloride solution
-
Chula Vista, California
- +14 more
Mar 15, 2022
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Detroit (Abelacimab, Dalteparin)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Dalteparin
-
Detroit, MichiganHenry Ford Health System
Jul 18, 2022
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Canada, United States (Abelacimab, Apixaban)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Apixaban
-
Lexington, Kentucky
- +2 more
Jun 6, 2022
Cardiac Implantable Electronic Devices on the Hemostatic System
Recruiting
- Thromboembolism
- +2 more
- Cardiac implantable electronic device implantation.
- +4 more
-
Ryazan', Ryazan, Russian FederationRyazan State Medical University
Oct 26, 2022
Healthy Trial in Liège (Ir-CPI - Dose 1, Ir-CPI - Dose 2, Ir-CPI - Dose 3)
Active, not recruiting
- Healthy
- Ir-CPI - Dose 1
- +4 more
-
Liège, BelgiumA.T.C. Pharma
Jul 19, 2022
Thrombus Trial in Hangzhou (SHR2285 tablet, Placebo)
Completed
- Thrombus
- SHR2285 tablet
- Placebo
-
Hangzhou, Zhejiang, ChinaZhejing Provincial People's Hospital
May 21, 2021